EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Antibody responses in Klebsiella pneumoniae bloodstream infection: a prospective cohort study

Wontae Hwang, Paeton L Wantuch, Biana Bernshtein, Julia A Zhiteneva, Damien M Slater, Kian Hutt Vater, Sushmita Sridhar, Elizabeth Oliver, David J Roach, Sowmya R Rao, Sarah E Turbett, Cory J Knoot und 6 weitere

The Lancet Microbe · 2025-04 · 6 (4) · 100988

DOI: 10.1016/j.lanmic.2024.100988 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift The Lancet Microbe, 2025-04. Verfasst von Wontae Hwang und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Antibodies, Bacterial, Klebsiella Infections, Bacteremia. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institutes of Health, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Klebsiella pneumoniae is a leading cause of infection-related deaths globally, yet little is known about human antibody responses to invasive K pneumoniae. We sought to determine whether the O-specific polysaccharide antigen is immunogenic in humans with K pneumoniae bloodstream infection. We also sought to define the cross-reactivity of human antibody responses among structurally related K pneumoniae O-specific polysaccharide subtypes and to assess the effect of capsule production on O-specific polysaccharide-targeted antibody binding and function. METHODS: In this prospective cohort study, we compared plasma antibody responses to O-specific polysaccharide in a cohort of consecutively enrolled patients with K pneumoniae bloodstream infection with controls, specifically a cohort of healthy individuals and a cohort of individuals with Enterococcus spp bloodstream infection. Patients were enrolled at the Massachusetts General Hospital, a tertiary hospital with affiliated clinics in the USA. We excluded patients whose isolates were not confirmed to be K pneumoniae by whole-genome sequencing. The primary outcome was the measurement of plasma IgG, IgM, and IgA antibody responses. We performed flow cytometry to measure the effects of K pneumoniae capsule production on O-specific polysaccharide antibody binding and O-specific polysaccharide antibody-mediated complement deposition, using patient isolates with variable levels of capsule production and isogenic capsule-deficient strains derived from these isolates. FINDINGS: We enrolled 129 consecutive patients with suspected K pneumoniae bloodstream infection between July 24, 2021, and August 4, 2022, of whom 69 patients (44 [64%] male and 25 [36%] female) with confirmed K pneumoniae bloodstream infection were eligible for immunological evaluation. Common O-specific polysaccharide serotypes (O1, O2, O3, and O5) accounted for 57 (83%) of 69 infections. O-specific polysaccharide was immunogenic in patients with K pneumoniae bloodstream infection, and peak O-specific polysaccharide-IgG antibody responses in patients were ten-fold to 30-fold higher than antibody responses detected in healthy controls, depending on the serotype. There was cross-reactivity among similar O-specific polysaccharide subtypes, including the O1v1 and O1v2, O2v1 and O2v2, and O3 and O3b subtypes, as well as between the O1 and O2 types. Capsule produced by both hyperencapsulated and non-hyperencapsulated K pneumoniae inhibited O-specific polysaccharide-targeted antibody binding and function. INTERPRETATION: O-specific polysaccharide was immunogenic in patients with K pneumoniae bloodstream infection, supporting its potential as a candidate vaccine antigen. The cross-reactivity observed between similar O-specific polysaccharide subtypes in patients with K pneumoniae bloodstream infection suggests that it might not be necessary to include all subtypes in an O-specific polysaccharide-based vaccine. However, these observations are tempered by the fact that capsule production, even in non-highly encapsulated strains, has the potential to interfere with O-specific polysaccharide antibody binding. This finding could limit the effectiveness of vaccines that exclusively target O-specific polysaccharide. FUNDING: National Institute of Allergy and Infectious Diseases at the National Institutes of Health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Klebsiella pneumoniaeAntibodies, BacterialKlebsiella InfectionsBacteremiaAntibody FormationHumansProspective StudiesMaleFemaleMiddle AgedImmunoglobulin GAgedO AntigensImmunoglobulin ABacterial CapsulesAdultCross ReactionsImmunoglobulin M

Substanzen

Antibodies, BacterialImmunoglobulin GO AntigensImmunoglobulin AImmunoglobulin M

Autor:innen und Institutionen

  • Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.
  • Department of Pediatrics, Division of Infectious Diseases, Washington University School of Medicine, Saint Louis, MO, USA.
  • Ragon Institute of Massachusetts General Hospital, Harvard and MIT, Cambridge, MA, USA.
  • Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA; Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
  • Department of Global Health, Boston University of Public Health, Boston, MA, USA.
  • Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA.

Förderung

  • NIAID NIH HHS
  • National Institutes of Health
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Hwang, W., Wantuch, P. L., Bernshtein, B., Zhiteneva, J. A., Slater, D. M., Vater, K. H., Sridhar, S., Oliver, E., Roach, D. J., Rao, S. R., Turbett, S. E., Knoot, C. J., Harding, C. M., Amin, M. N., Cross, A. S., LaRocque, R. C., Rosen, D. A., & Harris, J. B. (2025). Antibody responses in Klebsiella pneumoniae bloodstream infection: a prospective cohort study. The Lancet Microbe, 6(4), 100988. https://doi.org/10.1016/j.lanmic.2024.100988

Vancouver

Hwang W, Wantuch PL, Bernshtein B, Zhiteneva JA, Slater DM, Vater KH, et al. Antibody responses in Klebsiella pneumoniae bloodstream infection: a prospective cohort study. The Lancet Microbe. 2025;6(4):100988. doi:10.1016/j.lanmic.2024.100988

BibTeX
@article{Hwang2025,
  author = {Hwang, Wontae and Wantuch, Paeton L and Bernshtein, Biana and Zhiteneva, Julia A and Slater, Damien M and Vater, Kian Hutt and Sridhar, Sushmita and Oliver, Elizabeth and Roach, David J and Rao, Sowmya R and Turbett, Sarah E and Knoot, Cory J and Harding, Christian M and Amin, Mohammed Nurul and Cross, Alan S and LaRocque, Regina C and Rosen, David A and Harris, Jason B},
  title = {Antibody responses in Klebsiella pneumoniae bloodstream infection: a prospective cohort study},
  journal = {The Lancet Microbe},
  year = {2025},
  volume = {6},
  number = {4},
  pages = {100988},
  doi = {10.1016/j.lanmic.2024.100988}
}
Kostenlos starten →